CYP19A1 and cholangiocarcinoma: CCA line KKU-100 and KKU-213 cells also express elevated levels of aromatase compared to normal cholangiocytes, and inhibition of aromatase expression by siRNAs decreased cell proliferation and migration in KKU-213 cells [58].